Dr. Abbey Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read more
Dr. Anand and Dr. Abbey Receive Senior Honor Awards from the American Society of Retina Specialists (ASRS)
In recognition of their time and contributions to the scientific programs of the organization’s annual meetings, Texas Retina’s Rajiv Anand, MD, and Ashkan M. Abbey, MD, recently earned the Senior Honor Award
read more
July is UV Safety Month — Debunking Seven Common Myths About Sunglasses
When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July
read more
Offices Closed on Thursday, July 4, 2024
All Texas Retina Associates offices will be closed on Thursday, July 4, 2024, in recognition of the Independence Day holiday and will reopen on Friday, July 5. We wish everyone a safe
read more
June is Fireworks Eye Safety Awareness Month
Summer is here, and for many that means outdoor celebrations that include fireworks, especially around the 4th of July. Unfortunately, this also means an increase in eye injuries. Here are a few
read more
New, Larger Wichita Falls Office on the Way!
We’re excited to announce that construction is well underway on a new, larger Texas Retina Wichita Falls office designed to better serve our patients. The new office is located at: 6767 Southwest
read more
Celebrating Kim Russell’s 20 Years of Service to Texas Retina
As we continue to recognize team members who have been a part of the Texas Retina family for 20+ years, this week we are celebrating Kim Russell. She joined our practice in
read more
New Clinical Trials at Texas Retina
Over the past two decades, Texas Retina physicians have participated in more than 100 national clinical trials, offering our patients access to promising new treatments for a variety of retina conditions, including
read more
Dr. Abbey Presented Key Results of DAVIO 2 Clinical Trial for Wet AMD at Retina World Congress
At the recently held 2024 Retina World Congress Meeting, Texas Retina’s Dallas Director of Clinical Research Ashkan M. Abbey, MD, presented topline results from the DAVIO 2 clinical trial investigating EYP-1901 (Duravyu),
read more
Celebrating Rita Vega’s 21+ Years of Service to Texas Retina
We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we honor Rita Vegas, who joined Texas Retina in 2002 and currently serves
read more